Provided by Tiger Trade Technology Pte. Ltd.

AIM ImmunoTech Inc.

0.1904
+0.00271.44%
Volume:624.64K
Turnover:119.12K
Market Cap:7.60M
PE:-0.05
High:0.1934
Open:0.1913
Low:0.1884
Close:0.1877
52wk High:2.88
52wk Low:0.1659
Shares:39.89M
Float Shares:37.90M
Volume Ratio:1.70
T/O Rate:1.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9303
EPS(LYR):-30.8884
ROE:-2382.30%
ROA:-82.58%
PB:0.98
PE(LYR):-0.01

Loading ...

Silver Bullet Data Services Wins Shareholder Backing to Delist from AIM and Go Private

TIPRANKS
·
Jun 25

EPE Special Opportunities Increases Treasury Stock with AIM Share Buyback

TIPRANKS
·
Jun 25

CPP Group to Delist from AIM and Raise £5m to Support Blink Parametric

TIPRANKS
·
Jun 25

Hargreave Hale AIM VCT Cuts Share Count with Targeted Buyback

TIPRANKS
·
Jun 25

Maven Renovar VCT wins full AGM backing for AIM Plus strategy shift

TIPRANKS
·
Jun 24

Gana Media Director Increases Stake with AIM Share Purchase

TIPRANKS
·
Jun 24

AIM Immunotech Completes Phase 2 Duripanc Trial Enrollment for Ampligen-imfinzi in Metastatic Pancreatic Cancer

Reuters
·
Jun 24

AIM Immunotech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones

THOMSON REUTERS
·
Jun 24

AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones

GlobeNewswire
·
Jun 24

Blow to AIM as pawnbroker Ramsdens snapped up by US giant for £206m

cityam
·
Jun 23

M.P. Evans cuts share count with latest buyback on AIM

TIPRANKS
·
Jun 23

Vast Resources Extends Reverse Takeover Deadline as AIM Suspension Continues

TIPRANKS
·
Jun 23

Talon Resources Debuts on AIM as North American Gold Explorer with Eagle Lake Focus

TIPRANKS
·
Jun 23

AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series

GlobeNewswire
·
Jun 22

Restore plc Cancels 104,000 Shares After AIM Buyback

TIPRANKS
·
Jun 22

RentGuarantor Raises £1m in AIM Placing as Founder Trims Stake

TIPRANKS
·
Jun 20

B90 Chairman Increases Stake with AIM Share Purchase

TIPRANKS
·
Jun 19

Octopus AIM VCT 2 Cuts Share Count After Buyback, Updates Voting Rights

TIPRANKS
·
Jun 18

BRIEF-Aim Immunotech Duripanc Primary Endpoint Analysis To Begin December 2026 Topline Results Expected Q1 2027

Reuters
·
Jun 18

AIM ImmunoTech Trial of Ampligen With AstraZeneca's Imfinzi to Treat Pancreatic Cancers Doses Last Patient

MT Newswires Live
·
Jun 18